annual CFF:
-$80.95M-$535.05M(-117.83%)Summary
- As of today (July 1, 2025), AMPH annual cash flow from financing activities is -$80.95 million, with the most recent change of -$535.05 million (-117.83%) on December 31, 2024.
- During the last 3 years, AMPH annual CFF has fallen by -$43.94 million (-118.69%).
- AMPH annual CFF is now -117.83% below its all-time high of $454.09 million, reached on December 31, 2023.
Performance
AMPH Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$14.50M+$19.34M(+57.14%)Summary
- As of today (July 1, 2025), AMPH quarterly cash flow from financing activities is -$14.50 million, with the most recent change of +$19.34 million (+57.14%) on March 31, 2025.
- Over the past year, AMPH quarterly CFF has dropped by -$924.00 thousand (-6.80%).
- AMPH quarterly CFF is now -103.39% below its all-time high of $428.11 million, reached on June 30, 2023.
Performance
AMPH quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$81.88M-$924.00K(-1.14%)Summary
- As of today (July 1, 2025), AMPH TTM cash flow from financing activities is -$81.88 million, with the most recent change of -$924.00 thousand (-1.14%) on March 31, 2025.
- Over the past year, AMPH TTM CFF has dropped by -$535.94 million (-118.03%).
- AMPH TTM CFF is now -116.88% below its all-time high of $485.01 million, reached on September 30, 2023.
Performance
AMPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMPH Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -117.8% | -6.8% | -118.0% |
| 3 y3 years | -118.7% | -412.0% | -218.2% |
| 5 y5 years | -2039.9% | -26.7% | -517.3% |
AMPH Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -117.8% | at low | -103.4% | +69.2% | -116.9% | +13.1% |
| 5 y | 5-year | -117.8% | at low | -103.4% | +69.2% | -116.9% | +13.1% |
| alltime | all time | -117.8% | at low | -103.4% | +69.2% | -116.9% | +13.1% |
AMPH Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$14.50M(-57.1%) | -$81.88M(+1.1%) |
| Dec 2024 | -$80.95M(-117.8%) | -$33.84M(+48.3%) | -$80.95M(-14.1%) |
| Sep 2024 | - | -$22.82M(+112.9%) | -$94.19M(-718.3%) |
| Jun 2024 | - | -$10.72M(-21.1%) | $15.23M(-96.6%) |
| Mar 2024 | - | -$13.58M(-71.2%) | $454.06M(-0.0%) |
| Dec 2023 | $454.09M(-1817.5%) | -$47.08M(-154.4%) | $454.09M(-6.4%) |
| Sep 2023 | - | $86.61M(-79.8%) | $485.01M(+26.2%) |
| Jun 2023 | - | $428.11M(-3260.0%) | $384.47M(-961.4%) |
| Mar 2023 | - | -$13.55M(-16.2%) | -$44.63M(+68.8%) |
| Dec 2022 | -$26.44M(-28.6%) | -$16.16M(+16.0%) | -$26.44M(+39.4%) |
| Sep 2022 | - | -$13.93M(+1301.5%) | -$18.97M(-11.9%) |
| Jun 2022 | - | -$994.00K(-121.4%) | -$21.53M(-16.3%) |
| Mar 2022 | - | $4.65M(-153.4%) | -$25.73M(-30.5%) |
| Dec 2021 | -$37.02M(+1548.2%) | -$8.70M(-47.3%) | -$37.02M(+29.7%) |
| Sep 2021 | - | -$16.49M(+217.7%) | -$28.55M(+89.3%) |
| Jun 2021 | - | -$5.19M(-21.8%) | -$15.08M(-688.3%) |
| Mar 2021 | - | -$6.64M(+2824.7%) | $2.56M(-214.2%) |
| Dec 2020 | -$2.25M(-40.6%) | -$227.00K(-92.5%) | -$2.25M(-81.9%) |
| Sep 2020 | - | -$3.03M(-124.3%) | -$12.40M(-6.5%) |
| Jun 2020 | - | $12.46M(-208.8%) | -$13.26M(-49.9%) |
| Mar 2020 | - | -$11.45M(+10.3%) | -$26.46M(+599.5%) |
| Dec 2019 | -$3.78M(-115.1%) | -$10.38M(+167.0%) | -$3.78M(-116.1%) |
| Sep 2019 | - | -$3.89M(+424.0%) | $23.52M(-48.0%) |
| Jun 2019 | - | -$742.00K(-106.6%) | $45.21M(-3.9%) |
| Mar 2019 | - | $11.23M(-33.6%) | $47.06M(+88.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $25.01M(-424.0%) | $16.92M(-5.0%) | $25.01M(+243.3%) |
| Sep 2018 | - | $17.80M(+1504.0%) | $7.28M(-145.4%) |
| Jun 2018 | - | $1.11M(-110.3%) | -$16.03M(+134.8%) |
| Mar 2018 | - | -$10.83M(+1250.1%) | -$6.83M(-11.5%) |
| Dec 2017 | -$7.72M(-208.1%) | -$802.00K(-85.5%) | -$7.72M(-5.6%) |
| Sep 2017 | - | -$5.51M(-153.4%) | -$8.18M(-175.7%) |
| Jun 2017 | - | $10.31M(-188.0%) | $10.81M(+340.2%) |
| Mar 2017 | - | -$11.72M(+829.3%) | $2.46M(-65.6%) |
| Dec 2016 | $7.14M(+219.2%) | -$1.26M(-109.4%) | $7.14M(+152.3%) |
| Sep 2016 | - | $13.47M(+586.6%) | $2.83M(-119.7%) |
| Jun 2016 | - | $1.96M(-127.9%) | -$14.36M(+55.4%) |
| Mar 2016 | - | -$7.03M(+26.2%) | -$9.24M(-513.1%) |
| Dec 2015 | $2.24M(-93.0%) | -$5.57M(+49.7%) | $2.24M(-400.3%) |
| Sep 2015 | - | -$3.72M(-152.5%) | -$745.00K(-149.5%) |
| Jun 2015 | - | $7.08M(+59.4%) | $1.50M(-94.5%) |
| Mar 2015 | - | $4.45M(-152.0%) | $27.38M(-14.7%) |
| Dec 2014 | $32.12M(-442.8%) | -$8.55M(+481.0%) | $32.12M(-13.1%) |
| Sep 2014 | - | -$1.47M(-104.5%) | $36.97M(-4.7%) |
| Jun 2014 | - | $32.96M(+259.1%) | $38.80M(-498.7%) |
| Mar 2014 | - | $9.18M(-348.1%) | -$9.73M(+3.9%) |
| Dec 2013 | -$9.37M(-140.3%) | -$3.70M(-1130.6%) | -$9.37M(+65.3%) |
| Sep 2013 | - | $359.00K(-102.3%) | -$5.67M(-6.0%) |
| Jun 2013 | - | -$15.57M(-263.2%) | -$6.03M(-163.2%) |
| Mar 2013 | - | $9.54M | $9.54M |
| Dec 2012 | $23.24M(-371.0%) | - | - |
| Dec 2011 | -$8.58M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual CFF year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly CFF year-on-year change?
- What is Amphastar Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM CFF year-on-year change?
What is Amphastar Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AMPH is -$80.95M
What is the all time high annual CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash flow from financing activities is $454.09M
What is Amphastar Pharmaceuticals annual CFF year-on-year change?
Over the past year, AMPH annual cash flow from financing activities has changed by -$535.05M (-117.83%)
What is Amphastar Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AMPH is -$14.50M
What is the all time high quarterly CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash flow from financing activities is $428.11M
What is Amphastar Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AMPH quarterly cash flow from financing activities has changed by -$924.00K (-6.80%)
What is Amphastar Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AMPH is -$81.88M
What is the all time high TTM CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM cash flow from financing activities is $485.01M
What is Amphastar Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AMPH TTM cash flow from financing activities has changed by -$535.94M (-118.03%)